Effect of the percentage of body fat on surgical, clinical and pathological outcomes in women with endometrial cancer

Journal of Obstetrics and Gynaecology Research

Volumn 41, Issue 3, 2015, Pages 449-455

  Secilmis Kerimoglu, Ozlem ^a   Pekin, Aybike ^a   Yilmaz, Setenay Arzu ^a   Yavas, Guler ^a   Beyhekim, Fatma ^a   Demirtaş, Ayşe Ayda ^a   Dogan, Nasuh Utku ^b   Ilhan, Tolgay Tuyan ^a   Celik, Cetin ^a  

^a SELCUK UNIVERSITY   (Turkey)

^b AKDENIZ UNIVERSITY   (Turkey)

Author keywords

bioelectrical impedance analysis; body mass index; endometrial cancer; obesity; percentage of body fat

Indexed keywords

ADULT; ARTICLE; ASCITES FLUID CYTOLOGY; BLADDER INJURY; BLOOD VESSEL INJURY; BODY FAT; BODY MASS; BODY SIZE; DIABETES MELLITUS; ENDOMETRIUM CANCER; FEMALE; HUMAN; INTESTINE INJURY; MAJOR CLINICAL STUDY; OBESITY; OPERATION DURATION; OUTCOME ASSESSMENT; PARAAORTIC LYMPH NODE; PATIENT SELECTION; PEROPERATIVE COMPLICATION; POSTOPERATIVE COMPLICATION; RISK FACTOR; TOTAL BODY WATER; URETHRA INJURY; WOUND INFECTION; AGED; AORTA; CANCER STAGING; CARCINOMA, ENDOMETRIOID; COMPLICATION; ENDOMETRIAL NEOPLASMS; IMPEDANCE; LYMPH NODE DISSECTION; MIDDLE AGED; PATHOLOGY; TUMOR INVASION;

ADIPOSITY; ADULT; AGED; AORTA; BODY MASS INDEX; CARCINOMA, ENDOMETRIOID; ELECTRIC IMPEDANCE; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; LYMPH NODE EXCISION; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; OBESITY; OPERATIVE TIME;

EID: 84924720593     PISSN: 13418076     EISSN: 14470756     Source Type: Journal    
DOI: 10.1111/jog.12554     Document Type: Article

References (20)

1. Fader AN, Arriba LN, Frasure HE, et al. Endometrial cancer and obesity: Epidemiology, biomarkers, prevention and survivorship. Gynecol Oncol 2009; 114: 121-127.
2. von Gruenigen VE, Gil KM, Frasure HE, et al. The impact of obesity and age on quality of life in gynecologic surgery. Am J Obstet Gynecol 2005; 193: 1369-1375.
3. Schouten LJ, Goldbohm RA, van den Brandt PA,. Anthropometry, physical activity and endometrial cancer risk: Results from the Netherlands cohort study. J Natl Cancer Inst 2004; 96: 1635-1638.
4. World Health Organization Consultation on Obesity. Preventing and Managing the Global Epidemic: Report of A WHO Consultation on Obesity. Geneva, 3-5 June 1997, Geneva: WHO, 1998; 1-276.
5. Roubenoff R, Dallal GE, Wilson PW,. Predicting body fatness: The body mass index vs estimation by bioelectrical impedance. Am J Public Health 1995; 85: 726-768.
6. Seger JC, Horn DB, Westman EC, et al. Obesity Algorithm. American Society of Bariatric Physicians. 2014; [Cited 10 Jun 2014.] Available from URL: www.obesityalgorithm.org.
7. Waisbren E, Rosen H, Bader AM, et al. Percent body fat and prediction of surgical site infection. J Am Coll Surg 2010; 210: 381-389.
8. Modesitt SC, Geffel DL, Via J, et al. Morbidly obese women with and without endometrial cancer: Are there differences in measured physical fitness, body composition, or hormones? Gynecol Oncol 2012; 124: 431-436.
9. Okorodudu DO, Jumean MF, Montori VM, et al. Diagnostic performance of body mass index to identify obesity as defined by body adiposity: A systematic review and meta-analysis. Int J Obes (Lond) 2010; 34: 791-799.
10. Reeves KW, Carter GC, Rodabough RJ, et al. Obesity in relation to endometrial cancer risk and disease characteristics in the Women's Health Initiative. Gynecol Oncol 2011; 121: 376-382.
11. Das SK,. Body composition measurement in severe obesity. Curr Opin Clin Nutr Metab Care 2005; 8: 602-606.
12. Akbayir O, Corbacioglu Esmer A, Numanoglu C, et al. Influence of body mass index on clinicopathologic features, surgical morbidity and outcome in patients with endometrial cancer. Arch Gynecol Obstet 2012; 286: 1269-1276.
13. Everett E, Tamimi H, Greer B, et al. The effect of body mass index on clinical/pathologic features, surgical morbidity, and outcome in patients with endometrial cancer. Gynecol Oncol 2003; 90: 150-157.
14. Pavelka JC, Ben-Shachar I, Fowler JM, et al. Morbid obesity and endometrial cancer: Surgical, clinical, and pathologic outcomes in surgically managed patients. Gynecol Oncol 2004; 95: 588-592.
15. Jeong NH, Lee JM, Lee JK, et al. Role of body mass index as a risk and prognostic factor of endometrioid uterine cancer in Korean women. Gynecol Oncol 2010; 118: 24-28.
16. Martra F, Kunos C, Gibbons H, et al. Adjuvant treatment and survival in obese women with endometrial cancer: An international collaborative study. Am J Obstet Gynecol 2008; 198: 89.
17. Cymbaluk A, Chudecka-Glaz A, Rzepka-Gorska I,. Leptin levels in serum depending on body mass index with endometrial hyperplasia and cancer. Eur J Obstet Gynecol Reprod Biol 2008; 136: 74-77.
18. McCourt CK, Mutch DG, Gibb RK, et al. Body mass index: Relationship to clinical, pathologic and features of microsatellite instability in endometrial cancer. Gynecol Oncol 2007; 104: 535-539.
19. Anderson B, Connor JP, Andrews JI, et al. Obesity and prognosis in endometrial cancer. Am J Obstet Gynecol 1996; 174: 1171-1178.
20. Schmeler KM, Soliman PT, Sun CC, et al. Endometrial cancer in young, normal-weight women. Gynecol Oncol 2005; 99: 388-392.